Deprenyl in the treatment of patients with tetrahydrobiopterin deficiencies

Journal of Inherited Metabolic Disease

Volumn 23, Issue 4, 2000, Pages 329-332

  Schuler, A ^a   Kalmanchey R ^b   Barsi, P ^c   Somogyi, C S ^a   Toros I ^a   Varadi I ^a   Kovacs A ^b   Blau, N ^d  

^a Buda Children's Hospital   (Hungary)

^b Isotope Laboratory   (Hungary)

^c Isotope Laboratory   (Hungary)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; CARBIDOPA PLUS LEVODOPA; NEUROTRANSMITTER; PHENYLALANINE; SELEGILINE; TETRAHYDROBIOPTERIN;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; COGNITION; CONFERENCE PAPER; DIET RESTRICTION; DRUG EFFICACY; HUMAN; MOTOR PERFORMANCE; NUTRITIONAL DEFICIENCY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOPTERIN; CHILD; HUMANS; INFANT; MALE; MONOAMINE OXIDASE INHIBITORS; PHOSPHORUS-OXYGEN LYASES; SELEGILINE; TREATMENT OUTCOME;

EID: 0343294342     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005658625912     Document Type: Conference Paper

References (5)

1. Blau N (1996) The Hyperphenylalaninaemias: A Differential Diagnosis and International Database of Tetrahydrobiopterin Deficiencies. Marburg: Tectum Verlag, 24-35.
2. Knoll J (1998) (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. Pharmacol Toxicol 82: 57-66.
3. Schuler Á, Blau N, Ponzone A (1995) Monoaminooxidase inhibitors in tetrahydrobiopterin deficiency. Eur J Pediatr 154: 997.
4. Spada M, Schuler A, Blau N, Ferraris S, Lanza C, Ponzone A (1995) Deprenyl in 6-pyruvoyl tetrahydropterin synthase deficiency. Pteridines 6: 144-146.
5. Spada M, Blau N, Meli C, et al (1996) Different strategies in the treatment of dihydropteridine reductase deficiency. Pteridines 7: 107-109.